Immobilized fibrinogen activates human platelets through glycoprotein VI
Pierre H Mangin,
Marie-Blanche Onselaer,
Nicolas Receveur,
Nicolas Le Lay,
Alexander T Hardy,
Clare Wilson,
Ximena Sanchez,
Stéphane Loyau,
Arnaud Dupuis,
Amir K Babar,
Jeanette LC Miller,
Helen Philippou,
Craig E Hughes,
Andrew B Herr,
Robert AS Ariëns,
Diego Mezzano,
Martine Jandrot-Perrus,
Christian Gachet,
Steve P. Watson
Affiliations
Pierre H Mangin
Université de Strasbourg, INSERM, EFS Grand-Est, BPPS UMR-S 1255, FMTS, France
Marie-Blanche Onselaer
Institute of Cardiovascular Sciences, IBR Building, College of Medical and Dental Sciences, University of Birmingham, UK
Nicolas Receveur
Université de Strasbourg, INSERM, EFS Grand-Est, BPPS UMR-S 1255, FMTS, France
Nicolas Le Lay
Université de Paris Diderot, INSERM UMR_S1148, Hôpital Bichat, Paris, France
Alexander T Hardy
Institute of Cardiovascular Sciences, IBR Building, College of Medical and Dental Sciences, University of Birmingham, UK
Clare Wilson
Thrombosis and Tissue Repair Group, Institute of Cardiovascular and Metabolic Medicine, University of Leeds, UK
Ximena Sanchez
Laboratorio de Hemostasia, Pontificia Universidad Catolica de Chile, Santiago, Chile
Stéphane Loyau
Université de Paris Diderot, INSERM UMR_S1148, Hôpital Bichat, Paris, France
Arnaud Dupuis
Université de Strasbourg, INSERM, EFS Grand-Est, BPPS UMR-S 1255, FMTS, France
Amir K Babar
Division of Immunobiology, Center for Systems Immunology & Division of Infectious Diseases, Cincinnati, OH, USA
Jeanette LC Miller
Division of Immunobiology, Center for Systems Immunology & Division of Infectious Diseases, Cincinnati, OH, USA
Helen Philippou
Thrombosis and Tissue Repair Group, Institute of Cardiovascular and Metabolic Medicine, University of Leeds, UK
Craig E Hughes
Institute of Cardiovascular Sciences, IBR Building, College of Medical and Dental Sciences, University of Birmingham, UK;Institute for Cardiovascular and Metabolic Research, Harborne Building, University of Reading, UK
Andrew B Herr
Division of Immunobiology, Center for Systems Immunology & Division of Infectious Diseases, Cincinnati, OH, USA
Robert AS Ariëns
Thrombosis and Tissue Repair Group, Institute of Cardiovascular and Metabolic Medicine, University of Leeds, UK
Diego Mezzano
Laboratorio de Hemostasia, Pontificia Universidad Catolica de Chile, Santiago, Chile
Martine Jandrot-Perrus
Université de Paris Diderot, INSERM UMR_S1148, Hôpital Bichat, Paris, France;Acticor Biotech, Hôpital Bichat, INSERM, UMR-S 1148, Paris, France
Christian Gachet
Université de Strasbourg, INSERM, EFS Grand-Est, BPPS UMR-S 1255, FMTS, France
Steve P. Watson
Institute of Cardiovascular Sciences, IBR Building, College of Medical and Dental Sciences, University of Birmingham, UK;Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, Midlands, UK
Glycoprotein VI, a major platelet activation receptor for collagen and fibrin, is considered a particularly promising, safe antithrombotic target. In this study, we show that human glycoprotein VI signals upon platelet adhesion to fibrinogen. Full spreading of human platelets on fibrinogen was abolished in platelets from glycoprotein VI- deficient patients suggesting that fibrinogen activates platelets through glycoprotein VI. While mouse platelets failed to spread on fibrinogen, human-glycoprotein VI-transgenic mouse platelets showed full spreading and increased Ca2+ signaling through the tyrosine kinase Syk. Direct binding of fibrinogen to human glycoprotein VI was shown by surface plasmon resonance and by increased adhesion to fibrinogen of human glycoprotein VI-transfected RBL-2H3 cells relative to mock-transfected cells. Blockade of human glycoprotein VI with the Fab of the monoclonal antibody 9O12 impaired platelet aggregation on preformed platelet aggregates in flowing blood independent of collagen and fibrin exposure. These results demonstrate that human glycoprotein VI binds to immobilized fibrinogen and show that this contributes to platelet spreading and platelet aggregation under flow.